Navigation Links
Kevin Garrity Named President of HollisterStier Allergy
Date:4/26/2011

SPOKANE, Wash. April 26, 2011 /PRNewswire/ -- HollisterStier Allergy announced that they have recently added Kevin Garrity as the president of the business, illustrating the continued investment in the organization by their corporate parent, Jubilant Life Sciences, Ltd (Jubilant).  

(Photo:  http://photos.prnewswire.com/prnh/20110426/SF89673)

Garrity holds over 25 years of healthcare experience, 15 of which involved selling in vitro allergy diagnostic products and services.  Garrity recently held the title of General Manager and Chief Operating Officer for an in vitro diagnostics manufacturer and clinical laboratory service provider dedicated to immune hypersensitivities.  Garrity holds a Bachelor of Science in medical technology and a Master of Business Administration from Texas State University.  

HollisterStier Allergy has recently seen an influx of investment from Jubilant, evidenced by the completion of recent laboratory and production area expansions, the undertaking of research and development projects, and the addition of Garrity to HollisterStier Allergy leadership.

About HollisterStier Allergy

HollisterStier Allergy is a leading manufacturer of high-quality allergy products for the global market.  The organization provides a complete line of products for the testing and treatment of allergies.  HollisterStier Allergy's product portfolio includes many exclusive products, such as the Acetone Precipitated (AP)™ line of extracts and a complete line of skin testing devices including QUINTIP® and ComforTen®.  HollisterStier Allergy is owned by Jubilant Life Sciences, Ltd., and is located in Spokane, Washington.

For more info:  www.hsallergy.com

About Jubilant

Jubilant Life Sciences Limited (formerly Jubilant Organosys Ltd) is an integrated Pharma and Life Sciences Company. It is the largest Custom Research and Manufacturing Services (CRAMS) player and a leading Drug Discovery and Development Solution (DDDS) provider out of India. The Company provides Life Sciences products and services across the value chain. With 10 world-class manufacturing facilities and a team of ~5700 people across the globe, the Company is committed to deliver value to its customers spread across 60 countries. The Company is well recognized as a 'Partner of Choice' by leading life sciences companies worldwide.

For more info: www.jubl.com

MEDIA INQUIRIES:
Alison Marlin
509.951.0165
alison_marlin@hollister-stier.com


'/>"/>
SOURCE HollisterStier Allergy
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Verenium Appoints Kevin Bracken Vice President of Manufacturing
2. Kevin Kruse Named Executive Director of the Society of Pharmaceutical and Biotech Trainers
3. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
4. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
5. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
8. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
9. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
10. Concentric Named Professional Agency of Record for Discovery Labs SURFAXIN(R)
11. Expression Genetics EGEN-001 Named One of 10 Most Promising Oncology Products by Windhover
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
Breaking Biology Technology:
(Date:6/9/2016)... ISTANBUL , June 9, 2016  Perkotek an innovation leader in attendance control ... to seamlessly log work hours, for employers to make sure the right employees are ... Logo - http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/2/2016)... 2016 The Department of Transport Management ... 44 million US Dollar project, for the , ... Personalization, Enrolment, and IT Infrastructure , to ... and implementation of Identity Management Solutions. Numerous renowned international vendors ... Decatur was selected for the most compliant and ...
(Date:5/24/2016)... 2016 Ampronix facilitates superior patient care by providing unparalleled technology to leaders ... is the latest premium product recently added to the range of products distributed by ... ... ... LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):